The rising prevalence in GLP-1 agonists for diabetes has led to a discussion about delivery methods : transdermal systems versus pills . Usually , GLP-1 therapies were solely available in oral form, but https://jasonymqj522634.bluxeblog.com/73347822/glp-1-patches-vs-tablets-what-best-for-the-patient